|
Group
|
CD4+ (%)
|
CD8+ (%)
|
CD4+/CD8+ ratio
|
|---|
|
CE
|
24.2 ± 0.49
|
5.9 ± 0.93*
|
4.14 ± 0.57
|
|
4Cap(d41)
|
39.5 ± 0.7*
|
1.5 ± 0.04
|
27.1 ± 1.16*
|
|
Commercial vaccine
|
21.9 ± 0.85
|
1.2 ± 0.04
|
18.74 ± 1.4*
|
- The symbol (*) shows statastical differences between CE group and experimental groups (p < 0.05)